Assignee
DELPOR INC
US·11 granted patents·11 pending applications·79 citations·filing 2006–2024
Top patents by PatentIndex Score
22 records- 0198US9433574B2Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2015·Granted Sep 6, 2016·25 cites·10 claims
- 0296US7955614B2Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2006·Granted Jun 7, 2011·25 cites·25 claims
- 0391US8986727B2Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2013·Granted Mar 24, 2015·8 cites·16 claims
- 0489US9433573B2Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2015·Granted Sep 6, 2016·4 cites·13 claims
- 0588US9066876B2Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2013·Granted Jun 30, 2015·5 cites·11 claims
- 0687US9271926B2Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2015·Granted Mar 1, 2016·3 cites·10 claims
- 0786US9005650B2Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2013·Granted Apr 14, 2015·4 cites·13 claims
- 0884US10974036B2Implantable device for long-term delivery of drugsDELPOR INC·Filed 2019·Granted Apr 13, 2021·1 cites·14 claims
- 0982US9066875B2Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2013·Granted Jun 30, 2015·2 cites·12 claims
- 1080US10391288B2Implantable device for long-term delivery of drugsDELPOR INC·Filed 2016·Granted Aug 27, 2019·2 cites·17 claims
- 1170US2021205593A1Method of treating schizophrenia with an implantable device for long-term delivery of drugsDELPOR INC·Filed 2021·Application pending·0 cites
- 1269US2018193253A1Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2018·Application pending·0 cites
- 1367US2025009886A1Compositions for small molecule therapeutic agent compoundsDELPOR INC·Filed 2024·Application pending·0 cites
- 1465US2016374936A1Microfabricated nanopore device for sustained release of therapeutic agentDELPOR INC·Filed 2016·Application pending·0 cites
- 1564US2023390195A1Stable compositions for incretin mimetic compoundsDELPOR INC·Filed 2023·Application pending·0 cites
- 1654US2025152503A1Implantable devices for the sustained delivery of an opioid antagonist and methods for treating inflammatory, neuroinflammatory and metabolic disordersDELPOR INC·Filed 2023·Application pending·0 cites
- 1748US2019224122A1Stable compositions for incretin mimetic compoundsDELPOR INC·Filed 2017·Application pending·0 cites
- 1844US2022280503A1Compositions of opioid antagonists, implant devices, and treatment methods for opioid use disorderDELPOR INC·Filed 2020·Application pending·0 cites
- 1942US2022280494A1Compositions for small molecule therapeutic agent compoundsDELPOR INC·Filed 2020·Application pending·0 cites
- 2042US2021000740A1Compositions for small molecule therapeutic agent compoundsDELPOR INC·Filed 2019·Application pending·0 cites
- 2139US2019224322A1Compositions for small molecule therapeutic agent compoundsDELPOR INC·Filed 2017·Application pending·0 cites
- 2237US10137081B2Device and method for sustained release of antipsychotic medicationsDELPOR INC·Filed 2013·Granted Nov 27, 2018·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when DELPOR INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →